The newly approved oral formulation features a smaller pill size in 1.5mg, 4mg, and 9mg strengths while maintaining the efficacy and safety profile of the previous oral semaglutide version.
HealthDay News — Dietary and lifestyle modifications are reasonable first-line therapies for symptomatic hemorrhoids, according to a clinical practice update issued by the American Gastroenterological ...
Gene therapy approved to restore hereditary hearing loss; investigational treatment shows hair coverage improvements in male ...
The research suggests that the increase is partly due to introduction of the HAART drug regimen, which transformed HIV from a terminal condition into a manageable chronic disease. HealthDay News — ...
Patients received either mailed FIT with automated text message outreach from study personnel or mailed FIT-DNA with the ...
The Food and Drug Administration (FDA) has approved Auvelity ® (dextromethorphan HBr and bupropion HCl) for the treatment of agitation associated with dementia due to Alzheimer d ...
The Food and Drug Administration (FDA) has placed a hold on the enrollment of new patients in the phase 3 ENIGMA-TRS 2 study evaluating evenamide in treatment-resistant schizophre ...
HealthDay News — The US Food and Drug Administration (FDA) is moving to speed drug development and review by launching ...
However, most patients report preferring LAI-ART administered monthly or once every 2 months vs daily oral ART.
Novo Nordisk submitted a BLA to the Food and Drug Administration for denecimig for the treatment of hemophilia A in September 2025.
Similar incidence of death, new renal-replacement therapy, persistent kidney dysfunction reported with balanced fluid and 0.9 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results